Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Thursday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance Ampio Pharmaceuticals stock opened at $0.00 on Thursday. The company has a market cap of $2,508.00, a PE […]

Leave a Reply

Your email address will not be published.

Previous post Lords Group Trading’s (LORD) Buy Rating Reaffirmed at Berenberg Bank
Next post ALLETE (NYSE:ALE) Now Covered by StockNews.com